US Broker Ratings

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 18.84% Upside

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, offers an intriguing proposition for investors looking for growth opportunities in the healthcare industry. Headquartered in Minneapolis, Minnesota, Bio-Techne..

Incyte Corporation (INCY) Stock Analysis: Exploring a Strong 11.6% Potential Upside for Investors

Incyte Corporation (NASDAQ: INCY), a leading player in the biotechnology sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. Headquartered in Wilmington, Delaware, Incyte has made..

ICON plc (ICLR) Stock Analysis: A Strategic Play in Healthcare with 8.54% Upside Potential

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector, specifically within the diagnostics and research industry, stands out with its robust infrastructure in clinical research and development services...

Agilent Technologies, Inc. (A) Stock Analysis: Strong Buy Ratings and 19% Potential Upside Drive Investor Interest

Agilent Technologies, Inc. (NYSE: A), a leader in the diagnostics and research industry, continues to capture the attention of investors with strong buy ratings and a promising growth outlook. With..

argenx SE (ARGX) Stock Analysis: Envisioning a 23% Upside with Robust Revenue Growth

argenx SE (ARGX) is making waves in the biotechnology sector with its promising pipeline of autoimmune disease therapies. Based in Amsterdam, the Netherlands, this commercial-stage biopharma company has carved out..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.47% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands as a notable player in the healthcare sector, specifically within the niche of drug manufacturers focused on specialty and generic products. Headquartered in Silver..

Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 17% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio of innovative therapeutics targeting significant unmet medical needs. With a..

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Innovator with Nearly 20% Upside Potential

Qiagen N.V. (NASDAQ: QGEN) stands as a key player in the healthcare industry, specifically within the diagnostics and research segment. Headquartered in Venlo, the Netherlands, Qiagen specializes in transforming biological..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 26.64% Potential Upside in the Biotechnology Sector

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, is garnering attention from investors with its promising pipeline and potential upside of 26.64%, as indicated by recent analyst..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating the 17.52% Upside Potential for Investors

Doximity, Inc. (DOCS) is making waves in the healthcare sector, specifically within the health information services industry. With a current market capitalization of $3.91 billion, Doximity has established itself as..

Haleon plc (HLN) Investor Outlook: Unpacking a 29.58% Potential Upside in Healthcare Stocks

Haleon plc (HLN), a prominent player in the healthcare sector, has emerged as a point of interest for investors seeking stable growth opportunities in the drug manufacturing industry. As a..

Encompass Health Corporation (EHC) Stock Analysis: A 32.74% Potential Upside for Investors

Encompass Health Corporation (NYSE: EHC) is a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.5 billion, Encompass Health stands..

Humana Inc. (HUM) Stock Analysis: Navigating a Competitive Healthcare Landscape with a 23.5% Revenue Growth

Investors eyeing opportunities in the healthcare sector will find Humana Inc. (NYSE: HUM) a noteworthy contender, exhibiting notable resilience and growth amidst a rapidly evolving industry landscape. With a market..

Stryker Corporation (SYK) Stock Analysis: Exploring a 27.58% Upside Potential with Robust Analyst Support

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector specializing in medical devices, continues to capture the attention of investors thanks to its promising growth potential and a solid..

DaVita Inc. (DVA) Stock Analysis: High Return on Equity Highlights Investment Potential

Investors eyeing the healthcare sector may want to take a closer look at DaVita Inc. (NYSE: DVA), a leader in providing kidney dialysis services in the United States. With a..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strong Analyst Support

Exelixis, Inc. (NASDAQ: EXEL) has emerged as a formidable player in the biotechnology sector, focusing on groundbreaking oncology treatments. With a market capitalization of $12.69 billion, this U.S.-based company is..

Labcorp Holdings Inc. (LH) Stock Analysis: Unlocking 19.25% Potential Upside in the Healthcare Sector

For investors keen on the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents an intriguing opportunity. With a market capitalization of $21.32 billion, Labcorp stands as a significant player in..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential in a Challenging Market

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is an integrated pharmaceutical company with a strong presence in North America, Europe, India, Russia, and other..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating a Biotech Powerhouse with a -8.46% Potential Downside

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, has captured investor attention with its innovative approach to messenger RNA (mRNA) medicines. Based in Cambridge, Massachusetts, Moderna has..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 40.95% Potential Upside for Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, presents an intriguing opportunity for investors eyeing the medical instruments and supplies industry. With a market capitalization of $7.39..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds